Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best AOD-9604 Dosage Body Composition 2026: Protocol Comparison

Split-Dose Fasted 600mcg 300mcg AM fasted + 300mcg pre-sleep Maintain fasted state 60min post-AM dose, no food 2hr before PM dose Body recomposition in trained individuals (12–18% body fat) 1.5–2.5kg fat loss, muscle preservation Optimal alignment with circadi

This comparison does not assign a generated winner or score.

  • Split-Dose Fasted
  • 600mcg
  • 300mcg AM fasted + 300mcg pre-sleep
  • Maintain fasted state 60min post-AM dose, no food 2hr before PM dose
  • Body recomposition in trained individuals (12–18% body fat)
  • 1.5–2.5kg fat loss, muscle preservation
  • Optimal alignment with circadian lipolytic windows. Most evidence-supported for non-obese populations
  • Single-Dose Morning
  • 300–500mcg
  • Single injection upon waking, fasted state
  • 60min fasted window post-injection, movement recommended
  • Fat loss prioritization, simplified compliance
  • 1.0–1.8kg fat loss over baseline
  • Effective for adherence-limited users but sacrifices evening GH synergy
  • High-Dose Research
  • 1mg
  • Single daily injection (trial replication)
  • Variable. Trial did not control meal timing
  • Obesity (BMI >30), clinical trial replication
  • 2.6kg fat loss vs placebo (trial data)
  • Exceeds receptor saturation threshold. No evidence 1mg outperforms 600mcg split-dose in leaner populations
  • Evening-Only
  • 300mcg
  • Single injection 60min pre-sleep
  • No food 2hr pre-injection
  • Shift workers, fasted AM training not feasible
  • 0.8–1.5kg fat loss
  • Targets nocturnal GH pulse only. Sacrifices fasted morning lipolytic window
More references

Related material